eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement
Gross proceeds expected to include $60 million from a committed PIPE and up to $175 million held in trust Anticipated cash resources will...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page